An expert team from the National Clinical Research Center for Orthopedics and Sports Rehabilitation completed the first clinical application of Johnson & Johnson's arthritis Actis artificial femoral stem prosthesis in China at Boao Super Hospital on Dec 18.

Actis artificial femoral stem prosthesis adopts the new DUOFIX double-coating surface spraying technology, which is more suitable for minimally-invasive and precise operations. 

The special shape of the design can better adhere to the prosthesis and the bone, so that the patient can leave their sickbed earlier and recover faster.